Furthermore, the absence of signs of possible phytotoxic effect during in vivo trials and the wide availability of the pomegranate peel as a waste product of the processing factories, may facilitate the development of PGE as a commercial formulation.
Furthermore, the absence of signs of possible phytotoxic effect during in vivotrials and the wide availability of the pomegranate peel as a wasteproduct of the processing factories, may facilitate the developmentof PGE as a commercial formulation.